CVE-2023-27170
HIGHCVSS 7.5/10EPSS 0.79%
Last modified
CVE-2023-27170 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter.. EPSS estimates a 0.79% chance of exploitation in the next 30 days.
Description
Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter.
Metrics
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Xpand-It | Write-Back Manager | 2.3.1 |
References
- https://balwurk.com/cve-2023-27170-improper-limitation-of-a-pathname-to-a-restricted-directory/Exploit, Third Party Advisory
- https://balwurk.com/cve-2023-27170-improper-limitation-of-a-pathname-to-a-restricted-directory/Exploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-27170?
Xpand IT Write-back manager v2.3.1 allows attackers to perform a directory traversal via modification of the siteName parameter.
How severe is CVE-2023-27170?
CVE-2023-27170 has a CVSS score of 7.5/10 (HIGH severity). The EPSS model estimates a 0.79% probability of exploitation in the next 30 days.
How do I fix CVE-2023-27170?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-27170?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST